Status:
COMPLETED
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
Lead Sponsor:
Laboratoires Thea
Collaborating Sponsors:
Samil Pharmaceutical Co., Ltd.
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device. Evaluation o...
Eligibility Criteria
Inclusion
- Age ≥ 20 years old
- Patients with dry eye syndrome in allergic conjunctivitis
Exclusion
- Severe dry eye syndrome
- Severe ocular pathology
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01203540
Start Date
October 1 2010
End Date
January 1 2011
Last Update
January 31 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea
2
Seoul National University Boramae Medical Center
Seoul, South Korea